We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.75
Bid: 33.65
Ask: 34.20
Change: 0.85 (2.58%)
Spread: 0.55 (1.634%)
Open: 33.00
High: 34.05
Low: 32.70
Prev. Close: 32.90
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TR-1: Notification of major holdings

28 Apr 2021 09:31

RNS Number : 8669W
Futura Medical PLC
28 April 2021
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0033278473

Issuer Name

FUTURA MEDICAL PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

HT Riverwood Multi-Growth Fund

City of registered office (if applicable)

George Town

Country of registered office (if applicable)

Cayman Islands

4. Details of the shareholder

Is the shareholder the same as the person subject to the notification obligation, above?

Yes

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

21-Apr-2021

6. Date on which Issuer notified

21-Apr-2021

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

3.102000

0.000000

3.102000

7940000

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB0033278473

7940000

3.102000

Sub Total 8.A

7940000

3.102000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

HT Riverwood Multi-Growth Fund

HT Riverwood Multi-Growth Fund

3.102000

3.102000

10. In case of proxy voting

Is there proxy voting?

No

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

N/A

12. Date of Completion

27-Apr-2021

13. Place Of Completion

Hong Kong

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFIFFTSDITFIL
Date   Source Headline
4th May 20167:00 amRNSRecruitment Closes in MED2002 Study
26th Apr 201611:39 amRNSNotice of AGM
15th Mar 20167:00 amRNSPreliminary Results
7th Mar 20167:00 amRNSAppointment of Non-Executive Director
26th Feb 201612:00 pmRNSNotification of Major Interest in Shares
26th Jan 20167:00 amRNSCapital Markets Event
20th Jan 20167:00 amRNSCapital Markets Event
18th Jan 20162:33 pmRNSNotice of Preliminary Results
4th Jan 20161:15 pmRNSRemuneration of Non-Executive Directors
16th Dec 20157:00 amRNSExtends Shelf Life of CSD500
1st Dec 201510:13 amRNSNotification of Major Interest in Shares
24th Nov 20157:00 amRNSPositive Regulatory Update on Pain Portfolio
23rd Nov 20153:42 pmRNSBlocklisting Interim Review
23rd Nov 20153:18 pmRNSBlock Listing Update
17th Nov 20157:00 amRNSMED2002 Clinical Trial Update
23rd Oct 20157:00 amRNSNHS Reimbursement for MED2002 as a Special
14th Oct 20157:00 amRNSLicensing Agreement for MED2002
9th Oct 20157:30 amRNSNotification of Major Interest in Shares
10th Sep 20157:00 amRNSGrant of Options
9th Sep 20157:00 amRNSInterim Results
19th Aug 20153:15 pmRNSNotification of Major Interest in Shares
19th Aug 20157:00 amRNSNotice of Interim Results
16th Jul 20154:23 pmRNSNotification of Major Interest in Shares
14th Jul 20157:00 amRNSHeadline Results from Pain Relief Study
13th Jul 20157:00 amRNSNotice of Pain Relief Portfolio Study Results
25th Jun 20157:00 amRNSCommencement of MED2002 Clinical Trial
17th Jun 20155:45 pmRNSResult of AGM
17th Jun 20157:00 amRNSAGM Statement
3rd Jun 20155:20 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
18th May 20157:00 amRNSPain Relief Portfolio: Study Update
11th May 20157:00 amRNSBlock Listing Update
11th May 20157:00 amRNSBlue Diamond® Retail Roll-out
24th Apr 20153:00 pmRNSNotice of AGM
31st Mar 20155:05 pmRNSNotification of Major Interest in Shares
25th Mar 20157:00 amRNSPreliminary Results
18th Mar 20157:00 amRNSPain Relief Portfolio Study Commences
16th Mar 20155:48 pmRNSAIM Disclosure
3rd Mar 20154:52 pmRNSNotification of Major Interest in Shares
5th Feb 20157:00 amRNSUS Patent Extension for MED2002
2nd Feb 20151:18 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
28th Jan 20151:10 pmRNSNotification of Major Interest in Shares
23rd Jan 201510:14 amRNSNotification of Major Interest in Shares
22nd Jan 20152:33 pmRNSDirector Shareholding
15th Jan 201512:32 pmRNSNotification of Major Interest in Shares
15th Jan 201512:14 pmRNSDirector's Dealings
15th Jan 20157:00 amRNSNotice of Preliminary Results
5th Jan 20157:00 amRNSRemuneration of Non-Executive Directors
15th Dec 20147:00 amRNSAppointment of CRO for MED2002 Clinical Study
1st Dec 20147:00 amRNSUpdate on Pain Relief Clinical Programme
13th Nov 201410:02 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.